Ultracol
A PDO-based injectable listed by Clair for collagen-stimulation discussions. It is a different treatment format from inserting lifting threads, despite the shared material name.
- Approach
- Injectable treatment
- Your plan
- Assessed individually
How the approach works.
The source describes biodegradable PDO particles used as an injectable. The material, proposed area and individual skin or volume concern determine the consultation.
Understanding the anatomy
AI-generated educational illustrations, not patient photographs or treatment results. Simplified and not to scale; they do not show a recommended injection depth or an individual treatment plan.
The epidermis sits above the dermis, with subcutaneous fat deeper below. Layer thickness is schematic.
PDO particles and collagen
The source describes injectable PDO particles, not lifting threads. These two diagrams explain material and tissue concepts without promising a duration or amount of change.
PDO breakdown and collagen
Clair uses this diagram to discuss collagen changes after PDO particles break down. The drawing itself does not establish how long a response will last.
Connective tissue and volume
The source links collagen formation with volume. This tissue illustration explains the concept rather than predicting a patient’s appearance.
Illustrations from Clair’s official website. These simplified drawings are not patient results. The individual technique may differ.
What the consultation considers.
PDO material
Skin and volume goals
Previous treatment
This is a starting point for a consultation, not an individual treatment recommendation.
Structures to discuss
AI-generated educational illustrations, not patient photographs or treatment results. Simplified and not to scale; they do not show a recommended injection depth or an individual treatment plan.
A material-category illustration of separate particles within a tissue matrix; no product or injection location is specified.
Recovery, risks & limits.
Some reactions can be temporary; complications can also require treatment. This is not an exhaustive list.
Bruising, swelling, tenderness, lumps or delayed reactions can occur.
Infection and an unsatisfactory or uneven result may need further care.
Unintended injection into a blood vessel can cause tissue injury and, in facial injections, vision loss or stroke.
Your timeline is individual.
Procedure time, anaesthesia, follow-up and return travel depend on your examination and the final plan. Confirm them before paying for flights or accommodation.
Recovery and results vary. Your clinician should explain the procedure-specific risks and aftercare before you decide.
If you develop severe or worsening symptoms after treatment, seek medical attention rather than waiting for an online reply.
Dr. JinHo Han
Representative surgeon · Plastic surgery specialist
A personal consultation with a plastic surgery specialist. Discuss your facial features, skin condition and treatment preferences before deciding on a plan.
Your questions, answered.
Is this a thread lift?
No. The official page describes an injectable containing PDO particles. Thread lifting places threads under the skin and follows a different plan.
How long should I stay in Korea?
Procedure time, anaesthesia, follow-up and return travel depend on your examination and the final plan. Confirm them before paying for flights or accommodation.
Can I choose the procedure before an examination?
You can explore your options first. The final plan requires an examination, a discussion of alternatives and informed consent. Choosing no treatment is also an option.
How is the cost decided?
The clinic confirms the proposed method, treatment area and product or equipment before giving an individual quote. Ask what is included in follow-up care.
What should I disclose before treatment?
Tell the clinician about previous procedures, implants, medication, allergies and health conditions. Bring available details of earlier injections or surgery.
Sources & further reading
Clair Korean treatment informationPatient safety informationSource review: September 2026